Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousMelphalanGranulocyte Colony-Stimulating FactorAntigens, CD34LeukapheresisHematologic NeoplasmsCombined Modality TherapyStem Cell TransplantationBlood Component RemovalCyclophosphamideMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsGraft vs Host DiseaseStem CellsMyeloablative AgonistsHematopoietic Stem CellsBusulfanGraft SurvivalTreatment OutcomeBone Marrow TransplantationLymphoma, Non-HodgkinEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceCytophagocytosisCarmustineCord Blood Stem Cell TransplantationIfosfamideSalvage TherapyHematopoiesisVincristineAmyloidosisCytarabineTransplantation ChimeraDisease-Free SurvivalHodgkin DiseaseAutoimmune DiseasesTissue DonorsRetrospective StudiesNeoplasmsSurvival RateWhole-Body IrradiationTime FactorsSurvival AnalysisHistocompatibility TestingHistocompatibilityInfectionLymphoma, T-CellPlatelet CountDoxorubicinTransplantation, IsogeneicPOEMS SyndromeBlood Cell CountImmunosuppressive AgentsPrednisoneCarboplatinLeukemia, Myeloid, AcuteLeukemiaDexamethasoneVidarabineFollow-Up StudiesRecombinant ProteinsAntineoplastic AgentsBone Marrow PurgingEmbryonic Stem CellsBlood CellsLymphomaCytomegalovirus InfectionsProspective StudiesGraft vs Leukemia EffectFatal OutcomeFeasibility StudiesAdult Stem CellsImmunophenotypingMyelodysplastic SyndromesMesenchymal Stem Cell TransplantationLymphocyte DepletionT-LymphocytesAnemia, AplasticLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHematologic DiseasesHLA AntigensBlood Transfusion, AutologousFlow CytometryLiver TransplantationLeukocytes, MononuclearCell SeparationBone MarrowBlood DonorsCell DifferentiationPluripotent Stem CellsOpportunistic InfectionsHistiocytosis, Non-Langerhans-Cell